Let me understand this correctly... you want a finance / business analyst to comment on the FDA recent approval of a drug trial (based solely on safety, not efficacy)?
From a medical point of view? From a financial point of view? From a humanitarian point of view? What could you possibly hope to achieve with this "invitation to comment"?
It's pretty simple analysis:
Medically: it's safe (let's hope it's also effective)
Financial: Were not funding the trial - thank god
Humanitarian: Hope it works out for those poor kids.
- Forums
- ASX - By Stock
- MSB
- invitation to madamanswer to comment
MSB
mesoblast limited
Add to My Watchlist
2.99%
!
$1.72

invitation to madamanswer to comment, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.72 |
Change
0.050(2.99%) |
Mkt cap ! $2.204B |
Open | High | Low | Value | Volume |
$1.67 | $1.74 | $1.67 | $2.993M | 1.746M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 14570 | $1.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.72 | 36204 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 18328 | 1.715 |
19 | 41489 | 1.710 |
12 | 70372 | 1.705 |
13 | 97838 | 1.700 |
11 | 110895 | 1.695 |
Price($) | Vol. | No. |
---|---|---|
1.720 | 35115 | 26 |
1.725 | 44521 | 22 |
1.730 | 109194 | 17 |
1.735 | 132019 | 11 |
1.740 | 46765 | 12 |
Last trade - 12.24pm 15/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online